However, systemically injected labeled GLP1RAs show limited brain penetration, with the strongest labeling observed in circumventricular organs such as the AP and arcuate nucleus (ARC), suggesting that most central effects are mediated by downstream signaling from these primary GLP1RA binding sites 14
62 vvv vvvvvvvvv vvvvvvvvvv vv vvvvvv vvvvvvvv vvv vvvvvvv vv v vvvvvvv vvv vvvvvvvv vvvvvvv vvvvvvvvv vvvv vvvv vvvvvvvvvvv vvv vvv vvvv vvvvvvvvvvv vvv vvvvvvvvv vvvvvvvvvv vv vvvvvv vvvvvv vvv vvvvv vvvvv vvvv vvvvvvvvvvv vv vvv vvv vvvvv vv vv vvvv vvvvvvvvvvv vvvv vvvvvvv vvvvvv vvvvvvv vvvvv vvv vvvv vvvv vvvvv vvvvv vvvvvv vvv vvvvv vvvvv vv vvvvvvvvvvvv vvv vvvvvvv vvv vvvvv vv vv vvvvvvvvvv vvvvvvvvvv
To qualify for the Medicare GLP-1 Bridge program, patients must be classified as obese, meaning they have a body mass index (BMI) of 30 or greater
Practical clinical observation, multiple specialty surveys
Ongoing innovation, active clinical development, and expanding therapeutic indications are expected to sustain the market's growth trajectory in the foreseeable future
sex: F (1,19) = 0.4138, p = 0.5277